About Index Trending news
Analyze
Pricing
MicuRx Pharmaceuticals, Inc.

MicuRx Pharmaceuticals, Inc.

MicuRx Pharmaceuticals, Inc.

MicuRx is a clinicalstage biopharmaceutical company developing innovative antibiotics for multidrugresistant (MDR) bacterial infections including MRSA and VRE..

Elsewhere

Alexa global traffic share

26 Sep 2016
$55,000,000
Venture capital (Series C)
GP Healthcare Capital, GP TMT Capital, 3E Bioventures Capital, +3

MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I

yahoo
+2
22 Aug 2013
$25,000,000
Venture capital (Series B)
25 Jun 2007
$10,000,000
Venture capital (Series A)